Klivira
Request demo

Streamlining Medicare Tecentriq Prior Authorization Workflows

Managing Medicare Tecentriq prior authorization can be a significant administrative challenge for revenue cycle and prior authorization teams. Klivira provides a robust solution to automate and streamline these complex workflows, ensuring timely approvals for this critical oncology treatment.

Tecentriq (atezolizumab), a high-volume immunotherapy, requires prior authorization across many payer segments, including Medicare. Understanding the nuances between Original Medicare (Fee-for-Service) and Medicare Advantage plans is crucial for efficient claim processing and patient access. This page outlines the specific considerations for obtaining prior authorization for Tecentriq under Medicare.

Understanding Tecentriq Coverage Under Medicare

Tecentriq is typically administered intravenously in an outpatient setting, classifying it as a Part B drug for most Medicare beneficiaries. While Original Medicare has a limited scope for prior authorization, Medicare Advantage (MA) plans, which are managed by private insurers, often require extensive prior authorization for high-cost specialty drugs like Tecentriq. Medicare Part D plans would cover self-administered medications, but Tecentriq's administration typically falls under Part B.

Navigating Prior Authorization for Tecentriq with Original Medicare

For services covered by Traditional Medicare (Part A and B) that require prior authorization, submissions are routed through the responsible Medicare Administrative Contractor (MAC) for the provider's jurisdiction. Klivira's MAC-aware routing system is designed to handle these per-jurisdiction submission specifics, integrating National Coverage Determinations (NCDs) and Local Coverage Determinations (LCDs) published by CMS and the MACs, respectively. While the overall PA scope for Original Medicare is narrower, specific programs like outpatient department services PA or certain DME PA may apply to components of a patient's care plan.

Key Medicare Administrative Contractors (MACs) for Prior Authorization

  • Noridian Healthcare Solutions, LLC (Noridian)
  • National Government Services, Inc. (NGS)
  • Wisconsin Physicians Service Insurance Corporation (WPS)
  • Palmetto GBA (Palmetto)
  • First Coast Service Options (FCSO)
  • Novitas Solutions, Inc. (Novitas)

Prior Authorization for Tecentriq in Medicare Advantage Plans

Medicare Advantage plans (Part C), operated by private insurers, have an expanded scope for prior authorization compared to Original Medicare. These plans administer their own formularies, step-therapy protocols, and quantity limits, which frequently include requirements for specialty drugs like Tecentriq. The CMS-0057-F rule, while primarily impacting MA plans, mandates specific turnaround times and transparency requirements for prior authorization decisions, which Klivira helps providers meet through automated submission and tracking.

Klivira's Approach to Streamlining Medicare Tecentriq Prior Authorization

Klivira integrates directly with EMR systems and payer portals to automate the submission and tracking of prior authorizations for Tecentriq. For Original Medicare, our platform routes requests through the appropriate MAC jurisdiction, applying NCD/LCD-aware policy logic. For Medicare Advantage plans, Klivira manages the diverse requirements of commercial insurers, ensuring that all necessary clinical documentation and payer-specific forms (e.g., X12 278, ePA) are submitted accurately and efficiently, minimizing delays and reducing administrative burden.

Policy and Documentation Requirements for Tecentriq PA

Successful prior authorization for Tecentriq, whether under Original Medicare or Medicare Advantage, hinges on robust clinical documentation demonstrating medical necessity. Providers must ensure that patient records clearly support the prescribed indication as outlined in relevant NCDs, LCDs, or plan-specific medical policies. This often includes details on diagnosis, previous treatments, and patient-specific clinical criteria. Klivira facilitates the assembly and submission of this critical information, reducing the likelihood of denials due to incomplete or inaccurate data.

Frequently asked questions

Does Original Medicare always require prior authorization for Tecentriq?

No, Original Medicare has a limited scope for prior authorization. Tecentriq, as a Part B drug, may fall under specific PA programs if applicable, but most services under Traditional Medicare do not require it. Medicare Advantage plans, however, nearly always require PA for specialty drugs like Tecentriq.

How do Medicare Administrative Contractors (MACs) relate to Tecentriq prior authorization?

For Original Medicare services that do require prior authorization, MACs are responsible for processing these requests based on NCDs and LCDs. Klivira's system routes Tecentriq PA requests to the correct MAC based on the provider's jurisdiction, ensuring compliance with specific regional requirements.

What is the difference in prior authorization for Tecentriq between Original Medicare and Medicare Advantage?

Original Medicare's PA scope is limited, primarily relying on NCDs and LCDs for medical necessity. Medicare Advantage plans, being private insurance, have a broader and more extensive PA requirement, often including specific formularies, step therapy, and quantity limits for specialty drugs like Tecentriq. They are also subject to CMS-0057-F rules regarding PA turnaround times.

What documentation is typically needed for Tecentriq prior authorization under Medicare?

Required documentation typically includes patient demographics, diagnosis codes, clinical notes supporting the medical necessity for Tecentriq (e.g., pathology reports, prior treatment history, staging information), and the prescribing physician's order. Adherence to NCDs, LCDs, or plan-specific medical policies is crucial for approval.

How does Klivira help with Tecentriq prior authorization for Medicare patients?

Klivira automates the submission process by integrating with EMRs and payer portals. For Original Medicare, we ensure MAC-aware routing and NCD/LCD compliance. For Medicare Advantage, we manage diverse plan requirements, streamlining the submission of necessary clinical data and forms to accelerate approvals and reduce administrative burden.

Related coverage

Other tecentriq prior authorization by payer

Other tecentriq prior authorization by specialty

Ready to automate prior auth for this drug?

See how Klivira automates prior authorizations for your team.

Request a demo